Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Sternal Infusion for Postoperative Hyperalgesia
NCT00802048Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Feb 2009
- Primary completion
- Jan 2010
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, hyperalgesia, sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Feb 2009; status: terminated.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative painhyperalgesia
Beyond the preview
Go deeper on NCT00802048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00802048.